204 related articles for article (PubMed ID: 27133426)
21. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles.
Al-Rabia MW; Alhakamy NA; Rizg WY; Alghaith AF; Ahmed OAA; Fahmy UA
Drug Deliv; 2022 Dec; 29(1):807-820. PubMed ID: 35266425
[TBL] [Abstract][Full Text] [Related]
22. Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer.
Hurtado M; Sankpal UT; Ranjan A; Maram R; Vishwanatha JK; Nagaraju GP; El-Rayes BF; Basha R
Crit Rev Oncol Hematol; 2018 Jun; 126():201-207. PubMed ID: 29759562
[TBL] [Abstract][Full Text] [Related]
23. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
Bi YL; Min M; Shen W; Liu Y
Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
[TBL] [Abstract][Full Text] [Related]
24. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells.
Chang PY; Peng SF; Lee CY; Lu CC; Tsai SC; Shieh TM; Wu TS; Tu MG; Chen MY; Yang JS
Int J Oncol; 2013 Oct; 43(4):1141-50. PubMed ID: 23917396
[TBL] [Abstract][Full Text] [Related]
25. Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.
Choi ES; Shim JH; Jung JY; Kim HJ; Choi KH; Shin JA; Nam JS; Cho NP; Cho SD
Cancer Sci; 2011 Apr; 102(4):742-8. PubMed ID: 21241418
[TBL] [Abstract][Full Text] [Related]
26. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation.
Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Pu YS
Prostate; 2002 May; 51(3):211-8. PubMed ID: 11967955
[TBL] [Abstract][Full Text] [Related]
27. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells.
Abdallah FM; Helmy MW; Katary MA; Ghoneim AI
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693
[TBL] [Abstract][Full Text] [Related]
28. Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles.
Jiang S; Zhu R; He X; Wang J; Wang M; Qian Y; Wang S
Int J Nanomedicine; 2017; 12():167-178. PubMed ID: 28053531
[TBL] [Abstract][Full Text] [Related]
29. A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation.
Jeong JB; Yang X; Clark R; Choi J; Baek SJ; Lee SH
Carcinogenesis; 2013 Oct; 34(10):2350-60. PubMed ID: 23784084
[TBL] [Abstract][Full Text] [Related]
30. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
31. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
[TBL] [Abstract][Full Text] [Related]
32. Antitumor Effects of Glychionide-A Flavonoid in Human Pancreatic Carcinoma Cells Are Mediated by Activation of Apoptotic and Autophagic Pathways, Cell Cycle Arrest, and Disruption of Mitochondrial Membrane Potential.
Yu L; Chen M; Zhang R; Xu T
Med Sci Monit; 2019 Feb; 25():962-969. PubMed ID: 30712054
[TBL] [Abstract][Full Text] [Related]
33. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
Pathi S; Li X; Safe S
Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
[TBL] [Abstract][Full Text] [Related]
34. Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo.
Moghtaderi H; Sepehri H; Attari F
Biomed Pharmacother; 2017 Apr; 88():582-594. PubMed ID: 28152473
[TBL] [Abstract][Full Text] [Related]
35. Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice.
Colon J; Basha MR; Madero-Visbal R; Konduri S; Baker CH; Herrera LJ; Safe S; Sheikh-Hamad D; Abudayyeh A; Alvarado B; Abdelrahim M
Invest New Drugs; 2011 Feb; 29(1):41-51. PubMed ID: 19851711
[TBL] [Abstract][Full Text] [Related]
36. W346 inhibits cell growth, invasion, induces cycle arrest and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.
Xia Y; Weng B; Wang Z; Kang Y; Shi L; Huang G; Ying S; Du X; Chen Q; Jin R; Wu J; Liang G
Tumour Biol; 2016 Apr; 37(4):4791-801. PubMed ID: 26520440
[TBL] [Abstract][Full Text] [Related]
37. Combination use of tolfenamic acid with curcumin improves anti-inflammatory activity and reduces toxicity in mice.
Zhou W; Liu Q; Zang X; Hu M; Yue Y; Wang Y; Lv C; Du Z
J Food Biochem; 2020 Jun; 44(6):e13240. PubMed ID: 32281661
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of extrinsic apoptotic pathway in curcumin-mediated antiproliferative effect on human pancreatic carcinogenesis.
Youns M; Fathy GM
J Cell Biochem; 2013 Dec; 114(12):2654-65. PubMed ID: 23794119
[TBL] [Abstract][Full Text] [Related]
39. Reactive oxygen species mediate tolfenamic acid-induced apoptosis in human colorectal cancer cells.
Jeong JB; Choi J; Baek SJ; Lee SH
Arch Biochem Biophys; 2013 Sep; 537(2):168-75. PubMed ID: 23896517
[TBL] [Abstract][Full Text] [Related]
40. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway.
Cao L; Liu J; Zhang L; Xiao X; Li W
Oncol Rep; 2016 Oct; 36(4):2245-51. PubMed ID: 27572503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]